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Abstract
The role of phospholemman (PLM) in taurine and Cl3 efflux elicited by 30% hyposmotic solution was studied in cultured
cerebellar astrocytes with reduced PLM expression by antisense oligonucleotide (AO) treatment. PLM, a substrate for
protein kinases (PK) C and A, is a protein that increases an anion current in Xenopus oocytes and forms taurine-selective
channels in lipid bilayers. Taurine contributes as an osmolyte to regulatory volume decrease (RVD) and is highly permeable
through PLM channels in bilayers. Two antisense oligonucleotides (AO1 and AO2) effectively decreased the expression of
the PLM protein by 40% and 30%, respectively, and markedly reduced [3H]taurine efflux by 67% and 62%. AO treatment
also decreased the osmosensitive release of Cl3, followed as 125I. The inhibition of Cl3 efflux (23% for AO1 and 13% for
AO2) was notably lower than for [3H]taurine. The contribution of PKC and PKA in the function of PLM was also evaluated
in astrocytes. Pharmacological activation or inhibition of PKC and PKA revealed that the osmosensitive taurine efflux is
essentially PKC-independent while 125I efflux is reduced by the PKC blockers H-7 (21%) and Go«6983 (41%). The PKA
activator forskolin and dbcAMP increased taurine efflux by 66^70% and 125I efflux by 21^45%. Norepinephrine increased the
osmosensitive taurine efflux at about the same extent as dbcAMP and forskolin, and this was reduced by PKA blockers.
These results suggest that PLM plays a role in RVD in astrocytes by predominantly influencing taurine fluxes, which are
modulated by PKA but not PKC. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Taurine is part of the pool of organic osmolytes
contributing to cell volume recovery after swelling
[1,2]. This amino acid is present in large amounts
in excitable tissues, brain, heart and muscle, in which
it may attain concentration ranges of 10^40 mM [3].
Taurine e¥ux after hyposmotic swelling occurs in
essentially all cell types and the amino acid translo-
cates through a leak pathway, without involvement
of the energy-dependent transporter [2,4]. Remark-
ably, the swelling-evoked release of taurine is sensi-
tive to Cl3 channels blockers [5^7], and this has
raised the possibility of a common osmosensitive
pathway for taurine and Cl3, presumably an anion
channel-like molecule with broad selectivity [2,5].
Ionic currents carried by taurine through volume-ac-
tivated Cl3 channels have been recorded in C6 glio-
ma and in MDCK cells but its permeability through
this channel is very low as compared to Cl3 (Ptau/Cl
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0.2^0.4) [8,9]. This is in contrast to the ion channel
formed by the membrane protein phospholemman
(PLM). PLM was ¢rst isolated from canine cardiac
sarcolemma, where it is the major plasma membrane
substrate for cAMP-dependent protein kinase (PKA)
and protein kinase C (PKC) [10,11]. PLM is also the
major substrate phosphorylated by insulin and adre-
noceptor agonists in cardiac sarcolemma and in var-
ious other tissues [12^15]. PLM is a 15 kDa protein,
formed by only 72 amino acids [16]. When reconsti-
tuted in planar lipid bilayers, the PLM protein forms
a channel with the unique feature of switching
among conformations with di¡erent selectivity for
cations and anions [17]. Another uncommon prop-
erty of this channel is a very high selectivity for tau-
rine over a large selection of anions, including Cl3
[18]. The characteristic PLM transitions among
anion- and cation-selective conformations would al-
low the translocation of zwitterionic molecules such
as taurine, particularly if the spacing between its pos-
itive and negative charges adequately ¢ts the coun-
terion charges in the channel. PLM thus, appears to
be a suitable candidate for the osmodependent tau-
rine leak pathway. This molecule is widely expressed
in human and rat tissues, with skeletal muscle, heart
and brain showing highest expression levels [12^
15,19]. The involvement of PLM in the swelling-ac-
tivated taurine translocation is suggested by studies
showing more e⁄cient cell volume regulation and
increased taurine release in hyposmosis-stimulated
HEK cells overexpressing PLM [20,21]. In the
present work we further tested the role of PLM in
taurine transport, this time in cultured cerebellar as-
trocytes, by reducing PLM expression by antisense
oligonucleotides targeted against PLM, and follow-
ing the e¡ect of this maneuver on [3H]taurine and
Cl3 (traced by 125I) £uxes activated by hyposmolar-
ity. We also investigated whether PKC and PKA
blockers in£uence the osmosensitive taurine e¥ux
and its potentiation by norepinephrine. The e¡ect
of blockers was also examined on 125I £uxes acti-
vated by hyposmolarity.
2. Methods
Fetal calf serum, penicillin/streptomycin and lipo-
fectamine were obtained from Gibco (Grand Island,
NY). Trypsin, soybean trypsin inhibitor, DNase, for-
skolin and dibutiryl cAMP were obtained from Sig-
ma (St. Louis, MO). Phorbol 12-myristate 13-acetate
(PMA), H-7 and H-8 were purchased from RBI (Na-
tick, MD). [3H]Taurine and 125I were from New Eng-
land Nuclear (Boston, MA). All other chemicals
were of the purest grade available from regular com-
mercial sources.
2.1. Cell cultures and treatment with antisense
oligonucleotides
Cultures of cerebellar astrocytes were prepared as
previously described by Mora¤n and Patel [22].
Brie£y, the dissociated cell suspensions from the cer-
ebellum of newborn rats were plated at a density of
265U103 cells/cm2 in plastic dishes. The culture me-
dium contained basal Eagle’s medium supplemented
with 10% heat-inactivated fetal calf serum, 2 mM
glutamine, 50 U/ml penicillin, and 50 Wg/ml strepto-
mycin. The culture dishes were incubated at 37‡C in
a humidi¢ed 5% CO2/95% air atmosphere.
The phosphorothioate analogue of 25-mer sense
and two antisense oligonucleotides to the rat PLM
were synthesized. The PLM antisense-1 (AO1) oligo-
nucleotide sequence was 5P-AATCAAGATGTGGT-
GGAGAGGTGCC, which corresponds to a se-
quence of the rat PLM gene that £anks the ATG
start codon. The PLM antisense-2 (AO2) sequence
was 5P-AGAGGAGACACACACAGACAATCAA
which corresponds to the nucleotide sequence from
the 5P position 22 to 46 of the coding region of rat
PLM mRNA. A sense oligonucleotide (SO) corre-
sponding to the inverse sequence of AO1 was also
constructed as a control. An oligonucleotide was also
synthesized containing the nucleotides of AO1 with a
random sequence. The sequence of the oligonucleo-
tides revealed no identity with other sequences. The
oligonucleotides (10 WM, ¢nal) and lipofectamine
PLUS (Life Technologies) solutions were combined
with serum-free medium and added to cultured cer-
ebellar astrocytes during 6 h. Cells were washed and
incubated with a serum-containing medium and after
24 h cultures were used for release experiments or
lysed for Western blot analysis.
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2.2. Western blot analysis
Cells were washed twice with 37‡C phosphate-bu¡-
ered saline and homogenized in lysis bu¡er (50 mM
HEPES; 0.5 mM EDTA; 1% (v/v) NP-40; 0.25%
(w/v) SDS; 0.5 mM EGTA; 150 mM NaCl; 10 mM
DTT; 1 mM PMSF; 1 mM NaF; 2 Wg/ml aprotinin;
1 Wg/ml pepstatin; 5 Wg/ml leupeptin). Homogenates
(20^50 Wg protein per lane) were subjected to SDS-
PAGE [23]. The resolved proteins were transferred to
PDVF membranes at 200 mA for 1 h. The mem-
branes were blocked for 1 h with 5% nonfat dry
milk in TPBS (PBS, 0.1% (v/v) Tween 20) and
treated with a primary polyclonal antibody against
canine PLM (kindly donated by Dr. L.R. Jones, Uni-
versity of Indiana, USA), followed by an alkaline
phosphatase-linked secondary antibody. Bands were
visualized using enhanced chemiluminescence accord-
ing to the manufacturer’s protocol.
2.3. Release
Osmolyte release experiments were carried out as
previously described [5^7]. Cultured cells were loaded
by incubation at 37‡C with either [3H]taurine (20^40
Ci/mmol; 1.0 WCi/ml) for 1 h in the culture medium
or 125I (17 Ci/mg; 2.5 WCi/ml) for 15 min in isosmotic
medium. After loading, cells were washed three times
(5 min each) with isosmotic medium. For [3H]taurine
release experiments, cells were ¢rst incubated for
5 min in isosmotic medium and then for 5 min in
30% hyposmotic medium. Results are expressed as
the percentage of radioactivity released at each incu-
bation period of the total radioactivity accumulated
by cells during loading, excluding the washing peri-
od. For 125I e¥ux, due to the larger release and lower
retention of 125I by cells, the release of 125I was mea-
sured by collecting fractions every 20 s during 2.5
min in isosmotic medium and 2.5 min in hyposmotic
medium. At the end of the experiment, radioactivity
in the collected fractions and that remaining in the
cells were measured. Results are expressed as e¥ux
rate coe⁄cients as previously described [7] using
the following equation: r = [ln(R1)3ln(R2)]/(t13t2),
where R1 and R2 are the percentage of counts re-
maining in the cell layer at time t1 and t2, respec-
tively. In all parallel experiments control cells were
always treated with the vehicle of the tested com-
pounds.
2.4. Statistical analysis
Data were expressed as means þ S.E.M. and Stu-
dent’s t-test was used to compare the di¡erences be-
tween the means of two groups.
3. Results and discussion
The presence of PLM in astrocytes was examined
by the immunoblot analysis of astrocyte homoge-
nates, probed with polyclonal antibodies to the cyto-
plasmic domain of canine cardiac PLM. Results in
Fig. 1 showed that the antibody recognized only one
band with an approximate molecular mass of 15 kDa
Fig. 1. PLM expression in astrocytes treated with PLM anti-
sense oligonucleotides. Cells were treated with AO as detailed
in Section 2. (Top panel) After AO treatment, cells were ho-
mogenized and subjected to SDS-PAGE. Proteins were trans-
ferred to PDVF membranes, treated with a primary polyclonal
antibody against canine PLM, followed by an alkaline phospha-
tase-linked secondary antibody. Bands were visualized using en-
hanced chemiluminescence. (Bottom panel) Bands were mea-
sured by densitometric analysis using the Image/J program
(v.093e, NIH). Bars are means þ S.D. of densities in arbitrary
units of three determinations. C, control; AO1, antisense 1;
AO2, antisense 2; AOs, AO1 with a random sequence; S, sense.
Asterisk indicates statistically signi¢cant di¡erence from control
(*P6 0.001).
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(Fig. 1). Besides the cardiac sarcolemma, expression
of PLM has been reported in a variety of tissues,
including brain [19]. The present results demonstrate
its presence also in cultured cerebellar astrocytes. In
the supraoptical nucleus, PLM detected by in situ
hybridization is expressed essentially in neurons,
being absent in astrocytes [24]. This contrasts with
the robust expression of PLM found in this work in
cultured cerebellar astrocytes (Fig. 1). The meaning
of this di¡erence, so far unclear, might be related to
age or regional di¡erences, including the taurine con-
tent in astrocytes in the two preparations.
We were interested in assessing the involvement of
PLM as an osmosensitive pathway for taurine and
Cl3 transport activated by hyposmosis. This was ap-
proached in the present study by the strategy of de-
creasing the expression of PLM in astrocytes by anti-
sense oligonucleotides (AO), and then examine the
e¡ect of this maneuver on the osmosensitive £uxes
of taurine and Cl3. Two AO were constructed as
described in Section 2 which, as shown in Fig. 1,
e¡ectively decreased the expression of the PLM pro-
tein. Densitometric analysis of the blots shows a
40.5% and 27.2% decrease by AO1 and AO2, respec-
tively, as compared to the PLM expression in control
cells. A sense oligonucleotide was without e¡ect on
PLM levels (Fig. 1). Therefore, this strategy seems
useful to the purpose of this work.
3.1. E¡ect of AO on osmosensitive £uxes of
[3H]taurine and 125I
Control astrocytes previously treated with lipofec-
tin were exposed during 5 min to isosmotic medium
Fig. 2. Release of [3H]taurine induced by hyposmolarity in PLM antisense-treated astrocytes. Cells were loaded with [3H]taurine for
1 h and radioactivity release was measured as detailed in Section 2. In A, cells were washed and perfused for 3 min with isosmotic
medium and then with 30% hyposmotic medium and medium was collected each min. Results are the percentage of radioactivity re-
leased every minute of the total accumulated during loading. In B, cells were incubated 5 min in isosmotic medium and 5 min in 30%
hyposmotic medium. Bars are the di¡erence of the percentage of radioactivity released during the whole incubation period in hy-
posmotic medium minus radioactivity released in isosmotic medium. C, control cells ; SO, sense oligonucleotide; AO1 and AO2, anti-
sense 1 and 2 oligonucleotides. Values are means þ S.E.M. of 8^33 experiments. Asterisks indicate statistically signi¢cant di¡erence
from control (***P6 0.001).
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and thereafter the medium was replaced by 30% hy-
posmotic solution. Taurine release in isosmotic me-
dium was 6.5% of the total labeled pool and the
hyposmotic stimulus increased this release to 22.6%
(Fig. 2A). Treatment with AO resulted in a remark-
able reduction in taurine e¥ux from astrocytes. A
decrease of 67% (AO1) and 62% (AO2) in the net
stimulated taurine e¥ux was observed (net e¥ux de-
¢ned as stimulated e¥ux minus basal e¥ux) (Fig.
2B). The treatment increased basal release to 9.43%
(AO1) and 7.9% (AO2), P6 0.5. The sense oligonu-
cleotide constructed as control, did not signi¢cantly
a¡ect either the basal (not shown) or the stimulated
3H-taurine e¥ux (Fig. 2B).
The e¡ect of the AO was also tested on the osmo-
sensitive e¥ux of Cl3, followed as 125I. The AOs
decreased the release of 125I elicited by 30% hypo-
smotic solutions but the inhibition (23% for AO1
and 13% for AO2) was notably lower than for tau-
rine (Fig. 3). The treatment did not increase signi¢-
cantly the basal release of 125I (Fig. 3A). These re-
sults are in agreement with a previous study carried
out in HEK293 cells overexpressing PLM [21] in
which a marked increase of hyposmolarity-induced
release of taurine was observed, whereas the e¥ux
of 125I was clearly less a¡ected.
3.2. Role of PKC and PKA on osmolyte release
In cardiac sarcolemma and in other preparations,
PLM can be phosphorylated being a substrate of
both PKC and PKA [10^15]. That the phosphoryla-
tion, predominantly mediated by PKA, may modu-
late the function of PLM has been suggested in a
study in oocytes, showing that the Cl3 currents in-
creased by expression of PLM are ampli¢ed by coex-
pression with the catalytic subunit of PKA, the mag-
nitude of this e¡ect being dependent on the
amplitude of the basal current [25]. Therefore, the
question is raised of whether native PLM phosphor-
ylation is required for activation of osmolyte £uxes
in our preparation. As a ¢rst approach, here we an-
Fig. 3. Release of 125I induced by hyposmolarity in PLM antisense-treated astrocytes. Cells were cultured as described in Section 2
and loaded with 125I for 15 min. Cell were washed with isosmotic medium. 125I release was measured by collecting fractions every 20
s during 2.5 min in isosmotic and 2.5 min in 30% hyposmotic medium. In A results are expressed as e¥ux rate coe⁄cients. In B, bars
indicate e¥ux rate coe⁄cients at the maximal peak of 125I release by hyposmolarity. C, control cells ; SO, sense oligonucleotide; AO1
and AO2, antisense 1 and 2 oligonucleotides. Values are means þ S.E.M. of 8^16 experiments. Asterisks indicate statistically signi¢cant
di¡erence from control (*P6 0.02; **P6 0.01)
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alyzed the e¡ect of blockers and activators of PKC
and PKA on the hyposmotic-induced e¥ux of tau-
rine and 125I from astrocytes. Treatment of cells with
the PKC activator phorbol 12-myristate 13-acetate
(PMA) (100 nM) failed to modify the hyposmolar-
ity-stimulated e¥ux of taurine. The PKC blockers H-
7 (50 WM), chelerythrine (2.5 WM) and Go«6983 (1
WM) were either ine¡ective (H-7 and chelerythrine)
or marginally inhibitory (15%) (Table 1). These re-
sults indicate that PKC activation is not necessary
for swelling-stimulated transport of taurine, and in
case those £uxes occur in part via the PLM, PKC
phosphorylation of the protein is not required. It is
worthy to mention that swelling-activated taurine
£uxes appear largely independent of PKC in most
cell types so far examined [26]. 125I £uxes were
more sensitive than those of taurine to PKC blockers
in astrocytes, being 21% reduced by H-7 and 41% by
Go«6983. In other cells, the in£uence of PKC in vol-
ume-activated Cl3 currents appears cell speci¢c, with
results showing inhibition, activation or no e¡ect of
maneuvers manipulating the enzyme activity [27,28].
As for PKA, hyposmotic-stimulated e¥ux of tau-
rine remained una¡ected in astrocytes treated with
the PKA blockers H-8 (50 WM) and H-89 (50 WM)
(Table 1). However, PKA seems to modulate the
taurine osmosensitive pathway as demonstrated by
the e¡ect of forskolin (10 WM) or dbcAMP (1
mM), both activators of PKA, increasing by 70%
the release of taurine induced by hyposmolarity (Ta-
ble 1). In the same line are results in HEK cells
showing that K- and L-adrenoceptor stimulation
markedly increases hyposmosis-stimulated taurine ef-
£ux in both normal and overexpressed PLM cells
[21]. In cultured astrocytes, norepinephrine (100
WM) and isoproterenol (10 WM) also increased osmo-
sensitive taurine e¥ux to the same extent as dbcAMP
or forskolin (Fig. 4, Table 1). This stimulation was
50% reduced by PKA blockers, consistent with re-
sults in oocytes where the e¡ect of PKA coexpression
requires the intact phosphorylation sites in PLM [25].
Fluxes of 125I activated by swelling were partly
Table 1
E¡ect of blockers and activators of PKA and PKC on the ef-
£ux of [3H]taurine and 125I induced by hyposmolarity
Condition E¥ux rate coe⁄cient (min31)
[3H]Taurine 125I
Control 0.221 þ 0.008 0.739 þ 0.012
PMA (100 nM) 0.214 þ 0.014 0.772 þ 0.032
H-7 (50 WM) 0.231 þ 0.012 0.586 þ 0.06***
Go«6983 (1 WM) 0.190 þ 0.018* 0.433 þ 0.055***
Chelerythrine (2.5 WM) 0.201 þ 0.011
Forskolin (10 WM) 0.367 þ 0.046*** 1.076 þ 0.045***
dbcAMP (1 mM) 0.376 þ 0.071** 0.899 þ 0.047***
H-8 (50 WM) 0.208 þ 0.014 0.531 þ 0.32**
H-89 (50 WM) 0.229 þ 0.021
Astrocytes were loaded with [3H]taurine for 1 h or 125I for 15
min and radioactivity release was measured as detailed in Sec-
tion 2. Cells were preincubated with drugs for 10^60 min prior
to release and were present during the entire experiment. Re-
sults are expressed as e¥ux rate coe⁄cients at the maximal
peak of release. Values are means þ S.E.M. of 4^53 experiments.
Asterisks indicate statistically signi¢cant di¡erence from control
(*P6 0.05; **P6 0.02; ***P6 0.001).
Fig. 4. E¡ect of norepinephrine and isoproterenol on the release
of [3H]taurine induced by hyposmolarity. Cells were loaded
with [3H]taurine and treated with isosmotic and 30% hypos-
motic medium as described in Fig. 2A, in the presence or ab-
sence of 100 WM norepinephrine (NE) or (10 WM) isoproterenol
(IPT). Bars represent means of the percentage peak release in
each condition. Cells were preincubated with 50 WM H-8 and
H-89 during 30 min and the blockers were present throughout
the experiment. Values are means þ S.E.M. of 4^10 experiments.
Asterisks indicate statistically signi¢cant di¡erence from control
(*P6 0.02).
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increased by forskolin and dbcAMP and reduced by
the PKA blocker H-8, but these e¡ects were in all
cases less potent than for taurine £uxes (Table 1).
Based on the present results on the e¡ect of AO
and the susceptibility to drugs involved in phosphor-
ylation, it may be concluded that in astrocytes a
substantial amount of swelling-activated taurine ef-
£ux might occur via PLM, by a mechanism inde-
pendent of phosphorylation, but modulated by
PKA activity. An interesting observation derived
from the e¡ect of the AO is that PLM seems not
to play an important role on the osmosensitive Cl3
transport. These results contribute with additional
evidence to that so far available against a possible
shared pathway for taurine and Cl3 £uxes activated
by swelling. Against this common pathway are ¢nd-
ings of cell lines exhibiting Cl3 channels but not
taurine £uxes and conversely, cells responding to
swelling by activation of taurine £uxes without show-
ing osmosensitive Cl3 channel activity. In HeLa
cells, taurine and chloride release induced by hypo-
smolarity shows di¡erences in time course activation
[29]. Also, the two osmolytes exhibit a di¡erent phar-
macological pro¢le in HeLa and Ehrlich ascites cells
[29,30]. Furthermore, oocytes expressing various
cloned Cl3 channels exhibit taurine release without
expressing osmosensitive Cl3 channel activity [31].
The present results showed almost null participa-
tion of PLM on volume-sensitive Cl3 £uxes in astro-
cytes. The molecular identity of the volume-activated
Cl3 channel is still unknown. So far, a family of
seven membrane proteins with properties of Cl3
channels has been cloned and swelling activates
some of them. However, none of them exhibit the
characteristic features of the osmosensitive channels
activated in the cell [27,28]. The di¡erence observed
in the present work between taurine and Cl3 £uxes
in cells treated with AO may not be unexpected due
to the notably higher permeability of taurine as com-
pared to Cl3 through the channel formed by the
protein. As previously mentioned, this may be ex-
plained by the unique feature of PLM-formed chan-
nels which exhibit binding sites for anions and cati-
ons. This property would allow the passage of
zwitterions like taurine and possibly other amino
acids as well.
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